studies, the name Streptomyces albulus subsp. ochragerus subsp. nov. is proposed for the strain.
The microorganism produced two kinds of antibiotics; one identical with gougerotin, the other an amphoteric water soluble dipeptide containing L-alanine. The latter has the molecular formula CQH15N3O8 and is named alahopcin. It has a broad antibacterial spectrum and a synergistic effect with some other antibiotics against some antibiotic resistant staphylococci. Alahopcin has a low toxicity and was effective against experimental infections in mice caused by Staphylococcus aureus.
Of the several thousands microbial fermentation products that have been described, only few antibiotics have been reported to be selectively active against antibiotic resistant strains. NISHIKAwA and ISHIDA"" and ISHIDA et al.2"" discovered nojirimycin, which is selectively active against drug resistant Shigella. MITSUHASHI et al.'s reported that macarbomycin was more active against a resistant strain carrying episomes than against the original strain. In our screening program for new antibiotics, we searched for an antibiotic selectively active against an in vitro antibiotic resistant mutant of Staphylococcus aureus 209P (S. aureus 4R), because such an antibiotic might be active against the bacterial cell surface. We were successful and found several actinomycetes that produced an antibiotic selectively active against S. aureus 4R. The actinomycetes produced two kinds of antibiotics. One was found to be a new dipeptide antibiotic and was named alahopcin" ; the other was identical with gougerotin. In this paper, we describe the taxonomy of one of the producing organism, and the fermentation, isolation, and nhvcirn_rhimirnl anrd hinlnairnd nrnnertiec of n1, hnnrin
Materials and Methods

Screening Method
The modified spot inoculation method" was used for screening.
Taxonomic Studies
The morphological and cultural characteristics of the antibiotic producing organism were determined by the media and methods described by SHIRLING and GOTTLIEB". Previously described taxonomic keys and cultural descriptions'-13) were used to compare the culture with recognized genera and species.
Fermentation Studies
The microorganism was grown on glucose asparagine agar at 24°C for 10 days and a spore suspension (3 x 108 viable cells/ml) was prepared from the culture. Inocula were prepared by transferring 1 ml of the spore suspension into 2-liter flasks containing 500 ml of the seed culture medium consisting of glucose 2 %, soluble starch 3 ° o, soy bean flour I %, corn steep liquor 1 %, Polypepton (Daigo Nutritive Chem., Ltd.) 0.5 %, NaCI 0.3 %, CaCO, 0.5 % and Actcol (Takeda Chem. Inc.) 0.05 %, adjusted to pH 7.0 before sterilization. The flasks were incubated on a reciprocal shaker at 28°C for 40 hours. One liter of the culture was transferred into a 200-liter fermentor containing 100 liters of the seed culture medium. The seed culture was carried out at 28°C for 24 hours under aeration (100 liters/minute) and agitation (170 rpm). Fifty liters of the seed culture were transferred into a 2,000-liter fermentor containing 1,200 liters of the selected fermentation medium (as described in the Results). The fermentation was carried out at 24°C for 66 hours under aeration (1,200 liters/minute) and agitation (180 rpm). Inorganic phosphoric acid and ammonium nitrogen were determined by the modified NAKAMURA'S method") and the indophenol method", respectively. Glucose was determined with the glucose oxidase peroxidase system".
The growth in the fermentation broth was determined by packed cell volume.
Assay of Antibiotics
The amount of gougerotin was determined by the cup method on nutrient agar (Difco) using Escheric/ua coli IFO 12734 as the test organism. Sterilized 0.1 M phosphate buffer (pH 8.0) was used for dilution. The amount of alahopcin was determined by the paper disk method on an assay medium (medium A) consisting of glucose 3 %, sodium glutamate 0.5 %, K~HPO, 0.05 %, MgSO, • 7H,O 0.05 %, KC10.05 %, yeast extract (Difco) 0.05 %, Casamino Acids (Difco) 0.02 % and Bacto-agar (Difco) 1.5 %, adjusted to pH 7.0 before sterilization. Sterilized 0.1 M phosphate buffer (pH 6.0) was used for the dilution. S. aureus 4R was used as the test organism. The microorganism is a mutant strain derived from S. aureus FDA 209P (IFO 13267) in vitro and is resistant to tetracycline, erythromycin, chloramphenicol and streptomycin.
Isolation and Purification
The fermentation broth (980 liters) was adjusted to pH 5.0 with oxalic acid and filtered. The filtrate was adjusted to pH 7.5 with 3 N NaOH and passed through a column containing Amberlite IRC-50 (H+) (98 liters). Gougerotin was adsorbed on the resin and alahopcin passed through.
Gougerotin:
The antibiotic was eluted from the resin with 0.5 N HCl and the active eluate was adjusted to pH 7.0 with 0.5 N NaOH. The eluate was concentrated and chromatographed on activated carbon with water, on alumina with water, and then on activated carbon with water. The active eluate was concentrated, and MeOH -Me,CO (1: 1) was added to the concentrate to give colorless crystalline gougerotin. A 750-ml portion of the concentrate was adsorbed on an alumina (Merck, activated alumina 90, neutral, activity I) column (4.5 liters).
The column was washed with water and was eluted with 0.2 N aqueous ammonia.
The eluate was concentrated to 1 liter under reduced pressure. The concentrate was adsorbed on an Amberlite IRA-68 (OH-) column (1.5 liters). After the column was washed with water and with 0.1 M acetic acid, elution was carried out with 0.2 M acetic acid.
The eluate was concentrated and chromatographed on an activated carbon column (2 liters) with water. The fractions containing alahopcin were combined, concentrated under reduced pressure, and lyophilized to give 17.5 g of a white solid (purity: about 93 %). The white solid (1.0 g) was dissolved in 4 ml of 50 % aqueous methanol, diluted with 4 ml of 70 methanol, chromatographed on Sephadex LH-20 (swollen with 70% aqueous methanol), and eluted with 70% aqueous methanol. The eluate was concentrated and lyophilized to give 0.9 g of alahopcin.
Amino Acid Analysis
Alahopcin was hydrolized with 6 N HCI at 100°C for 15 hours and analyzed with an amino acid analyzer (Jeol-JLC BC2).
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Antimicrobial Activities
The activities were determined by the agar serial two-fold dilution method. The synergistic effect was calculated by the method of ALLEN et al.").
Protective Effect in Mice
The protective effect of alahopcin was studied on groups of five mice (male Slc: ICR, 18 -22 g) infected intraperitoneally with S. aureus 308A-1. The antibiotic was administrated intraperitoneally, subcutaneously, or orally in single dosage regimen immediately after infection (0 hour), or in three times dosage regimens at 0, 1 and 3 hours post-infection. The 50 % effective dose (ED,,, mg/kg) was calculated from the survival rate after seven days.
Results
Screening
Among about 2,000 strains isolated, four were selectively active against S. aureus 4R. The sources and antimicrobial activities of these four are shown in Table 1 . On the basis of their taxonomic properties, and antimicrobial spectra, the strains were considered to belong to the same species. Strain
No. B-52653 was used for further study because of its high antibiotic productivity.
Taxonomy
The vegetative mycelium develops well on almost all media. The aerial mycelium is simply branch- The color of the reverse side is pale yellow to brown. A light yellow to pale brown diffusible pigment was noted in some media. The strain is considered to be non-chromogenic. The cultural and physiological properties are shown in Tables 2   and 3 , respectively. 
Fermentation
During the fermentation studies, it was found that the strain produced two kinds of antibiotics.
One was active against E. coli and the other was selectively active against S. aureus 4R.
After investigating various media and conditions for obtaining a high yield of the latter antibiotic, the following composition of a medium was selected: FeSO} I g, MgSO3.7H~O 0.2 g, KH2POa 1. 
Glucose (C), NH:,-N (s), total P (A), potency (C and •), packed cell volume (•) and pH (------).
Properties of the Antibiotics
The antibiotic that was active against E. coli was identified as gougerotin"'. formamide. It is positive to the ninhydrin and Greig-Leaback peptide tests, but negative to the Sakaguchi, anthrone-H2SO, and orcinol-H,SO, tests.
The antibiotic is stable in water at pH 1 -13 for 10 minutes at 100°C and unstable in alkaline rather than in acidic solution.
The UV absorption spectrum in water shows end absorption. The IR absorption and the NMR spectrum at 90 MHz are shown in Figs. 2 and 3 , respectively. Hydrolysis of the antibiotic gave an acidic amino acid (a-aminotricarballylic acid), L-alanine and ammonia.
The structure of alahopcin was determined to be (2S,3R)-2-[(L-alanyl)amino]-4-formyl-3-(hydroxyaminocarbonyl)butyric acid by chemical and enzymatic degradation studies and spectrometric studies, and the NMR spectrum at 400 MHz in D..,O (Table 4) revealed that alahopcin exists in a mixture of two The activity of the antibiotic was affected by the kind of assay medium and the inoculum size of the test organism.
As shown in Table 6 , the antibiotic exhibits a broad spectrum of activity on synthetic and by using larger amount of the inoculum.
As shown in The intravenous and intraperitoneal administration of 1,000 mg/kg of alahopcin into mice did not result in any toxic symptoms for two weeks after the injection. The protective effects of alahopcin against experimental infection caused by S. aureus 308A-1 in mice were as follows: the ED,, in single dosage regimen by the intraperitoneal, subcutaneous or oral route was 17.7, 70 and more than 600 mg/ kg, respectively; the ED,, in the three times dosage regimen by the subcutaneous route was 27.5 mg/kg.
Discussion
Alahopcin was found to be an antibiotic that is selectively active against an antibiotic resistant mutant and it is considered to be a kind of antimetabolite on the basis of its activities in various assay media. It had no activity (MIC: 800 pg/ml) against S. aureus 308A-1 (inoculum: 10S cfu/ml) on nutrient rich assay medium such as Trypticase Soy Agar (BBL), though it was effective against experimental infection of this test organism in mice. It showed synergistic activity with erythromycin against drug resistant bacteria, especially constitutive-type macrolide resistant strains even on the nutrient rich assay medium.
Its mechanism of action is assumed to be related to the inhibition of bacterial cell wall synthesis, because it inhibited the incorporation of [1-'H]-N-acetyl.lucosamine and [3H]diaminopimeric acid into the mucopeptide of S. aureus and E. coli, respectively (unpublished data). In addition, the antibiotic inhibits collagen prolylhydroxylase in vitro and in vivo and has a similar degree of activity as that of Nacetylmuramyl-L-alanyl-D-isoglutamine on the production of humoral antibody to bacterial a-amylase (unpublished data).
Since alahopcin has such characteristic biological and chemical properties, it is assumed that the compound will be a starting material for various semisynthetic derivatives.
